| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0518083be7a75216160acbc8240eb2ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ec1bdc1142ec9ed2f8a99fff3aa0735 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S128-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40 |
| filingDate |
2010-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54afbb4331ad7ca04d58a30d2a230cfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a8b79d500cb17ebf9a3bd501fb1abe |
| publicationDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011082707-A1 |
| titleOfInvention |
Methods For Delivering A Drug To A Patient While Restricting Access To The Drug By Patients For Whom The Drug May Be Contraindicated |
| abstract |
Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11200971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018075220-A1 |
| priorityDate |
2000-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |